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Abstract
During brain development, growth cones respond to attractive and repulsive axon guidance cues. How growth cones
integrate guidance instructions is poorly understood. Here, we demonstrate a link between BDNF (brain derived
neurotrophic factor), promoting axonal branching and ephrin-A5, mediating axonal repulsion via Eph receptor tyrosine
kinase activation. BDNF enhanced growth cone filopodial dynamics and neurite branching of primary neurons. We show
that ephrin-A5 antagonized this BDNF-evoked neuronal motility. BDNF increased ERK phosphorylation (P-ERK) and nuclear
ERK entry. Ephrin-A5 suppressed BDNF-induced ERK activity and might sequester P-ERK in the cytoplasm. Neurotrophins
are well established stimulators of a neuronal immediate early gene (IEG) response. This is confirmed in this study by e.g. c-
fos, Egr1 and Arc upregulation upon BDNF application. This BDNF-evoked IEG response required the transcription factor
SRF (serum response factor). Notably, ephrin-A5 suppressed a BDNF-evoked neuronal IEG response, suggesting a role of
Eph receptors in modulating gene expression. In opposite to IEGs, long-term ephrin-A5 application induced cytoskeletal
gene expression of tropomyosin and actinin. To uncover specific Eph receptors mediating ephrin-As impact on
neurotrophin signaling, EphA7 deficient mice were analyzed. In EphA7 deficient neurons alterations in growth cone
morphology were observed. However, ephrin-A5 still counteracted neurotrophin signaling suggesting that EphA7 is not
required for ephrin and BDNF crosstalk. In sum, our data suggest an interaction of ephrin-As and neurotrophin signaling
pathways converging at ERK signaling and nuclear gene activity. As ephrins are involved in development and function of
many organs, such modulation of receptor tyrosine kinase signaling and gene expression by Ephs might not be limited to
the nervous system.
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Introduction
During brain development, axons encounter attractive and
repulsive guidance cues, whose interplay instructs growth cones
with directional information, thereby ensuring target recognition.
For instance, axons initially overshoot their final termination zone
until, later on, such ectopic arborizations are eliminated and only
branches in the prospective termination zone are stabilized, a
process termed axon pruning [1,2]. In the hippocampus, mossy
fibers are subject to axon pruning [3]. The overshooting requires
growth-promoting/attractive molecules such as neurotrophins [4],
whereas axon retraction involves growth-inhibiting/repulsive cues
such as ephrins [5,6,7,8].
Here, we studied axon guidance responses elicited by ephrin-A
and BDNF co-stimulation of mouse primary neurons. Eph family
members signal bi-directionally. In EphA forward signaling,
ephrin-A ligands can activate multiple Eph receptor tyrosine
kinase receptors (EphA1-EphA8 and also e.g. EphB2; see below) in
a highly promiscuous manner. This usually results in contact-
mediated repulsion, e.g. growth cone collapse [9,10,11]. Intracellular
signal propagation via EphA receptors involves e.g. Rho-GTPases,
Src and MAP kinases [9,11,12,13]. In Eph reverse signaling,
membrane-bound ephrin-As are ‘‘receptors’’ activated by EphA
‘‘ligands’’. This results in attractive [14] and repulsive [15,16,17]
axon guidance responses, depending on e.g. axonal subtype
investigated. Ephrin-As such as ephrin-A5 used in this study might
activate the EphB2 in addition to multiple well-established EphA
receptors[18].Therefore,ephrin-A5activatesEphAandpotentially
also EphB2 forward signaling (in this study summarized as Eph
forward signaling).
BDNF is considered an attractive axon guidance cue, e.g.
promoting retinal axon branching [16,19,20] and neurite out-
growth [4,21,22,23]. Signaling of BDNF via the TrkB receptor
results in e.g. PI3 kinase and MAP kinase activation [24]. In fact,
BDNF requires MAP kinase activity to convey its impact on
processes of neuronal motility as demonstrated by pharmacological
inhibition of MAP kinase signaling [25,26,27]. BDNF modulates
gene expression [24,28,29], which has not been reported in detail
for Eph family members so far. Recently, SRF (serum response
factor) emerged as transcription factor targeted by neurotrophins
[30,31,32,33]. SRF regulates neuronal activity-induced immediate
early gene (IEG; e.g. Egr1, c-fos, Arc) and actin cytoskeletal gene
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outgrowth, axon guidance, growth cone motility [30,36,37],
synapse function [38,39] and myelination [40] is impaired.
So far, an interaction of EphA forward signaling and neurotro-
phins has not been analyzed in detail. In contrast, a crosstalk
between EphA reverse and neurotrophin signaling is well docu-
mented [16,17,41]. Besides neurotrophins, EphAs communicate
with GDNF/Ret signaling to guide motor axons [42,43].
Here, we demonstrate an interaction of ephrin-A and
neurotrophin signaling in primary hippocampal and cortical
neurons. Activation of Eph forward signaling by ephrin-A5
antagonized BDNF-enhanced neuronal motility in vitro. Ephrin-
A5 application attenuated BDNF-stimulated ERK activity by
suppression of ERK phosphorylation. Ephrin-A5 incubation
resulted in co-localization of phosphorylated ERK and Eph
receptors in the neurites. Eph forward signaling suppressed a
BDNF-evoked IEG response conveyed by SRF. As demonstrated
by EphA7 deficient neurons, EphA7 is dispensable for ephrin-A’s
influence on neurotrophin signaling.
Taken together, our data suggest a counteraction of neurotro-
phin signaling by ephrin-As. This finding might also be applicable
to signaling processes regulated by Eph family members outside of
the nervous system, e.g. in organogenesis and tumorigenesis.
Materials and Methods
Animals
Srf (flex1neo/flex1neo) and Camk2a-iCre mice were bred to obtain
Srf mutants (Srf




+/–; Camk2a-iCre [35,36]). Recombination induced by Cre
recombinase expression via the Camk2a promoter starts just before
birth and results in strong SRF down-regulation at time-points
used to culture primary neurons [35,36]. EphA7 mice were kindly
provided by U. Drescher (King’s College, London, UK; see [15]).
Animal experiments and housing were approved by the local
ethics committee (Einrichtung fu ¨r Tierschutz, Tiera ¨rztlichen
Dienst und Labortierkunde, Calwer Straße 7/4, 72076 Tu ¨bingen,
Tu ¨bingen University; permit number: 14 Anzeige 15/10/2009).
Neuronal cell culture
P1 hippocampal or E17.5 cortical cultures were incubated in
NMEM/B27 medium as described previously [36]. In brief,
neurons (5610
3–10
4) were cultured on poly-L-lysine (100 mg/ml;
Sigma) and laminin (20 mg/ml; Gibco) coated coverslips (13 mm).
Ephrin-A5-Fc (R&D systems) or Fc alone (Sigma) was applied to
the culture medium at 1 mg/ml, both pre-clustered with 10 mg/ml
anti-human IgG Fc-specific (Sigma) for 30 mins at 37uC. BDNF
was applied at 10 ng/ml (Fig. 1). Stimulation was performed for
45 min at 37uC (Fig. 1). For experiments with U-0126 (Cell
Signaling), cells were pre-incubated with U-0126 at 10 mM for 1h
before application of BDNF. For biochemistry (Fig. 2) and qRT-
PCR, cortical neurons (approx. 10
6 cells/35 mm dish coated with
poly-L-lysine at 10 mg/ml) were cultured for 3 div (days in vitro)
prior to stimulation (see below). We used nucleofection (Amaxa,
Cologne, Germany) to deliver a constitutively-active mutant of
MEK1 [44] into cortical or hippocampal neurons.
Biochemistry
Cortical cultures were stimulated with 1 mg/ml clustered (see
above) ephrin-A5-Fc and/or BDNF (10 ng/ml) in NMEM/B27
medium for the indicated time periods. Phosphatase inhibitors
were applied for 15 mins prior to ephrin-A5-Fc and/or BDNF
stimulation: sodium vanadate (200 mM; Sigma), okadaic acid
(200 nM; Calbiochem), PhosStop (1x; Roche). Cells were lysed in
100 mM Tris pH 7.8, 150 mM NaCl, 1 mM EDTA, 1% Triton-X-
100, 0.1% SDS and protease inhibitors (Roche). Samples were
resolved on 10-12% SDS-PAGE, followed by transfer on PVDF
membranes (Amersham). After blocking, first antibodies were
applied overnight at 4uC: rabbit anti-ERK (1:1000; Cell Signaling),
rabbit anti-P-ERK (1:1000; Cell Signaling), mouse anti-GAPDH
(1:50000), rabbit anti-TrkB (1:1000; Santa Cruz), rabbit anti-P-
TrkB (1:1000; Cell Signaling), mouse anti-EphA4 (1:750; BD
Transduction Laboratories), P-EphA3 (1:10000, gift of Dr. M.
Greenberg, Harvard Medical School, Boston). Detection of first
antibodies involved horseradish-peroxidase conjugated secondary
antibodies (1:5000) and the ECL Western Blotting Substrate
(Pierce).
Quantitative real-time PCR (qRT-PCR)
Cultures were stimulated with 2.5 ng/ml BDNF and/or 1 mg/
ml pre-clustered ephrin-A5-Fc (see above). Total RNA was
isolated with the RNeasy kit (Qiagen). Reverse transcription was
performed with 1 mg RNA using reverse transcriptase (Promega)
and random hexamers. qRT-PCR was performed on ABI PRISM
7700 Sequence Detector with the Power PCR SYBR green PCR
master mix (Applied Biosystems). Expression was determined in
relation to Gapdh RNA levels. Primer sequences can be obtained
upon request.
Immunocytochemistry
Cells were fixed for 15 minutes in 4% PFA/5% Sucrose/PBS,
permeabilized for 5 minutes in 0.1% Triton-X-100/PBS and
blocked for 30 minutes in 2% BSA/PBS. Primary antibodies were
incubated overnight at 4uC as follows: mouse a-ß-tubulin (1:5000;
Sigma), mouse a-class III ß-tubulin (1:1000; Covance), rabbit anti-
ERK (1:300; Cell Signaling), rabbit anti-P-ERK (1:300; Cell
Signaling). First antibodies were detected with Alexa 488 or 546-
conjugated secondary antibodies (1:1000; Molecular Probes). Cells
were stained for F-actin with Texas Red-X Phalloidin (1:100;
Molecular Probes).
For visualization of P-ERK and Eph receptors, cultures were
incubated with 1 mg/ml pre-clustered ephrin-A5 for 20 minutes,
followed by fixation with 4%PFA/sucrose for 15 minutes. Ephrin-
A5 bound to Eph receptors was visualized with anti-Fc Cy3
conjugated antibodies (1:300 in block). Subsequently, P-ERK
staining was performed as indicated above.
Image acquisition and statistics
Pictures were acquired on a Zeiss Axiovert 200M or Zeiss LSM
confocal microscope using an Axiocam camera and Axiovision
software. We used 10x, 20x and 63x Zeiss objective lenses with
numerical apertures of 0.3, 0.8 and 1.3 (oil), respectively. Pictures
were further processed using Photoshop software (Adobe).
For data in Fig. 1 and Fig. S1, four independent experiments
were performed. In each experiment 20 neurons/condition were
analyzed. Filopodia number (.1 mm) and growth cone surface
was determined for all growth cones/neuron using Axiovision
software. For quantification of neurite number and branches, only
neurites of more than 30 mm and branches of more than 2 mm
were included. In Fig. 2, three independent cultures/condition
were analyzed using Image Quant software (Molecular Dynamics).
To evaluate ERK nuclear translocation (Fig. 3), four independent
experiments including 25 neurons/experiment/condition were
analyzed. A ratio of cytoplasmic vs. nuclear P-ERK intensity was
determined using Axiovision software. In qRT-PCR, RNA of at
least three independent cultures/condition was harvested.
Statistical significance was assessed by using a two-tailed t-test
(Excel software) with *, **, *** representing P#0.05, 0.01, 0.001.
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Results
Ephrin-A5 stimulation counteracts BDNF-induced
neuronal motility in vitro in an SRF-dependent manner
To study an interplay between ephrin-A and BDNF stimulated
neuronal signaling, we investigated growth cone morphology
(Fig. 1) and neurite branching (Fig. S1) of primary hippocampal
neurons. In a first set of experiments, neurons were incubated with
soluble ephrin-A5, BDNF or both together for 45 minutes (Fig. 1).
In line with retinal growth cones [45], BDNF enhanced filopodia
number, length and overall growth cone area (Fig. 1E, F)
compared to non-treated wild-type neurons (Fig. 1A, B; see
quantification in Q and R). Contrastingly, ephrin-A5 resulted in
growth cone collapse as reported before [36,37,46]. When
simultaneously adding ephrin-A5 and BDNF, growth cones
collapsed (Fig. 1M, N). A similar result was recently reported for
retinal growth cones [47]. Besides filopodia number (Fig. 1Q) and
overall growth cone area (Fig. 1R), ephrin-A5 also counteracted a
BDNF-mediated increase in filopodia length (data not shown).
Next, we asked whether both guidance cues require SRF gene
activity to influence growth cone motility. As before [36,37], Srf
mutant growth cones lacked filopodia, therefore appearing in a
‘‘rounded’’ shape (Fig. 1C, D). Neuronal phenotypes evoked by
SRF deficiency, including reduced growth cone filopodia number,
decreased branching and neurite outgrowth can be rescued by
expression of constitutively-active SRF-VP16 in SRF deficient
neurons [36,48]. BDNF failed to induce filopodia (Fig. 1G, H),
ephrin-A5, alone (Fig. 1K, L) or together with BDNF (Fig. 1O, P),
was unable to induce a full growth cone collapse in Srf mutant
neurons. Instead, ephrin-A5 alone (Fig. 1K, L [36,37] or together
with BDNF (Fig. 1O, P) induced F-actin and microtubule rings in
SRF deficient growth cones.
Besides growth cone morphology (Fig. 1), we analyzed neurite
andsecondarybranchformation(Fig.S1).BDNFstimulated neurite
and branch formation was inhibited by ephrin-A5 in an SRF
dependent manner (Fig. S1). This BDNF function most likely
requires MAP kinase signaling as shown in many instances before
[25,26,27]. In accordance, BDNF mediated short-term stimulation
to increase filopodia number and growth cone area (Fig. 1S, T)
required MAP kinase signaling as demonstrated by pharmacolog-
ical interference with U-0126, a MEK inhibitor. Further, long-term
effects stimulated via BDNF such as an increase in primary neurite
number (Fig. S1) was likewise dependent on ERK signaling.
In sum, Eph forward signaling impaired BDNF-induced growth
cone motility and neurite/branch formation in vitro. Similar to
NGF-mediated responses on peripheral axons [30], BDNF
signaling required SRF mediated gene expression.
Ephrin-As counteract BDNF signaling via suppression of
ERK kinase activity
Next, we investigated the underlying signaling mechanism,
whereby ephrin-As and neurotrophins might interact. Focus was
given on MAP kinases and especially ERK as a possible signaling
mediator regulated by receptors of both guidance cues (see
Introduction). Upon activation by ephrins, Eph receptors activate
[49,50,51] or inactivate [46,52,53,54,55,56] MAP kinases de-
pending on e.g. cell type and Eph subclass implicated.
For these biochemical experiments requiring larger amounts of
neuronal tissue, cortical neurons rather than hippocampal neurons
were employed (Fig. 2). Both neuronal cell types behave identical
in many parameters (ephrin-A5 induced growth cone collapse,
ERK activation and e.g. BDNF-evoked gene expression; own data
not shown). Therefore, data obtained should be interchangeable
with both neuron types.
Short-term activation of Eph forward signaling by ephrin-A5
application suppressed ERK kinase activation as revealed by decreased
ERK1 and ERK2 phosphorylation (P-ERK). In agreement with our
data, EphA activation also decreased ERK signaling in hippocampal
neurons [46] and cortical neurons [55]. During longer exposure to
ephrin-A5 (.1h), P-ERK returned to control levels (Fig. 2A).
Application of BDNF alone expectedly increased P-ERK levels
(Fig. 2B). Notably, when ephrin-A5 was co-applied with BDNF,
ERK activity was reduced. This suggests that ephrin-A5
counteracted ERK activation by BDNF (Fig. 2B).
One way by which ephrin-A5 might inhibit ERK phosphory-
lation is recruitment of phosphatase activity, which has been
implicated as downstream effector of an EphA mediated growth
cone collapse [46]. Indeed, pre-incubation with various phosphatase
inhibitors (i.e. okadaic acid, OA, blocking serine/threonine
phosphatases; sodium vanadate, SV, a protein-tyrosine phosphatase
inhibitor and a pan-phosphatase inhibitor coctail, mix) prevented
ephrin-A5 from inhibiting ERK activity (Fig. 2C). EphA receptor
phosphorylation assessed by P-EphA3 levels was not obviously
altered by application of either phosphatase inhibitor (Fig. 2C and
data not shown). We further analyzed whether ephrin-A5 also
requires phosphatases to reduce BDNF-induced P-ERK levels
(Fig. 2D; n=3 independent experiments). In contrast to ephrin-A5
alone (Fig. 2C) we did not observe an major requirement of
phosphatases to mediate this effectof ephrin-A5 on BDNF-mediated
ERK phosphorylation (Fig. 2D). Only in the presence of the
phosphatase inhibitor mix (mix) we observed a slight reconstitution
of P-ERK levels comparable to BDNF treatment alone (Fig. 2D).
Eph forward signaling induces ERK activation within the
neurites while impairs BDNF induced p-ERK activation
and its subsequent nuclear translocation
Subsequently to ERK phosphorylation, neurotrophins stimulate
cytoplasmic to nuclear P-ERK translocation allowing for modulation
Figure 1. Ephrin-A5 treatment blocks BDNF-induced growth cone motility in an SRF-dependent manner. Wild-type and SRF-deficient
hippocampal neurons were stimulated with ephrin-A5 and/or BDNF as indicated for 45 min, followed by F-actin (red) and microtubule (green)
staining. Individual growth cones are highlighted with arrows. (A-D) Wild-type neurons protruded multiple growth cones elaborating finger-like
filopodia (A, higher magnification B). In Srf mutants (C, D), growth cones were rounded without any obvious filopodia. (E-H) BDNF enhanced growth
cone area and filopodia number in wild-type neurons (E, F). BDNF required SRF gene activity to modulate filopodia number, as revealed by Srf mutant
neurons remaining unaltered by BDNF treatment (G, H). (I–L) Ephrin-A5 induced growth cone collapse decreasing filopodia number and growth cone
area (I, J). In SRF-deficient growth cones, ephrin-A5 application resulted in ring-like structures consisting of F-actin and microtubules (K, L). (M-P) Co-
application of ephrin-A5 with BDNF in wild-type neurons counteracted BDNF-stimulated growth cone motility (M, N). Now, growth cones were
collapsed (M, N) rather than increased in area as induced by BDNF alone (see E, F). In SRF-deficient neurons (O, P), growth cones protruded ring-like
structures as seen with ephrin-A5 alone (K, L). (Q) Quantification of filopodia number/growth cone for the various treatments and genotypes.
Statistical significance was calculated relative to wild-type/control condition. (R) The average growth cone area (wild-type and control condition set
to 100%) was quantified. (S, T) Upon inhibition of MEK by U-0126, BDNF fails to increase filopodia number (S) and growth cone area (T). Scale-bar (A,
C, E, G, I, K, M, O) = 10 mm; (B, D, F, H, J, L, N, P) = 2 mm.
doi:10.1371/journal.pone.0026089.g001
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experiments (Fig. 2), immunofluorescence microscopy was employed
to investigate the sub-cellular localization of P-ERK in neurons
treated under the various conditions (Fig. 3). Indeed, stimulation of
neurons for 15 to 45 minutes with BDNF alone (Fig. 3E-H)
expectedly elevated nuclear P-ERK levels (indicated by arrows)
compared to non-treated cells (Fig. 3A-D; see quantification in Q).
This finding is in line with Western Blotting experiments (Fig. 2B)
Figure 2. Ephrin-A5 suppresses ERK activation and inhibits BDNF-evoked ERK phosphorylation. (A) Cortical neurons were stimulated
with ephrin-A5 for time-points indicated. EphA receptor activation (assessed by P-EphA3) suppressed ERK phosphorylation. At later time points (120–
240 mins), EphA receptors were less active and ERK phosphorylation returned to control levels (‘‘–’’, untreated). Quantification of results depicts P-ERK
levels relative to control treatment (set to1). (B) BDNF alone elevated P-ERK levels, whereas ephrin-A5 alone inhibited ERK phosphorylation. Ephrin-A5
inhibited BDNF-induced elevation of P-ERK. Neither EphA nor TrkB receptor activation was influenced by co-application of both substances. (C) Eph
forward signaling requires phosphatases to suppress ERK phosphorylation. Neurons were pre-treated with phosphatase inhibitors (OA, ocadaic acid;
SV, sodium vanadate; mix, commercially available phosphatase inhibitor mix). In the presence of either phosphatase inhibitor, ephrin-A5 failed to
inhibit ERK phosphorylation. Quantification depicts P-ERK levels relative to control (without treatment and inhibitor set to 1) for OA and SV. (D)
Ephrin-A5 does reduce BDNF-stimulated P-ERK levels in the presence of phosphatase inhibitors.
doi:10.1371/journal.pone.0026089.g002
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analyzed whether ephrin-A5 blocks BDNF signal propagation on the
levelofnuclearP-ERKaccumulation(Fig.3).Ephreceptoractivation
by ephrin-A5 prevented ERK activation as measured by P-ERK
levels in the nucleus, (Fig. 3I-L and Q). Notably, upon ephrin-A5
applicationP-ERKnowaccumulatedinneurites(arrowheadsFig.3I).
Similar to incubation with ephrin-A5 alone, we observed that ephrin-
A5 co-applied with BDNF was able to reduce nuclear P-ERK
(Fig. 3M-P). Instead, as seen for ephrin-A5 alone (Fig. 3I), we
observed P-ERK signals in neurites (arrowhead Fig. 3M). Total ERK
levels were not obviously altered by any of the treatments (Fig. 3R-U;
see also Fig. 2). Of note, these P-ERK clusters co-localized with Eph
receptors in neurites upon ephrin-A5 application (Fig. 3V-X) but not
in the un-stimulated situation (data not shown).
In sum, Eph forward signaling impaired BDNF mediated P-
ERK activation.
Eph forward signaling modulates BDNF-evoked IEG
expression
Nuclear P-ERK enhances gene transcription by activating
many transcription factors, including SRF [31]. As Ephrin-A5
impairs BDNF elicited ERK activation and its subsequent nuclear
translocation, we addressed the potential consequences of Ephrin-
A5 treatment on BDNF-mediated gene expression (Fig. 4). Focus
was given on a well-established neurotrophin mediated gene
expression program, the IEG response (see introduction). For this,
cortical neurons derived from wild-type or Srf mutant embryos
were treated for 20 minutes or 4h with ephrin-A5, BDNF or both
substances applied simultaneously. Subsequently, IEG mRNA
levels were assessed by quantitative real-time PCR.
BDNF alone elicited in wild-type neurons a robust IEG
response at both time-points, as revealed by induction of c-fos
(Fig. 4B, C), Egr1 (Fig. 4D, E), Egr2 (Fig. 4F, G) and Arc (Fig. 4H,
I). Srf abundance was not altered by this short BDNF exposure (i.e.
20 mins; Fig. 4A) in contrast to longer exposure times [32]. Eph
forward signaling alone did not obviously alter IEG induction at
any time-point (Fig. 4A-I). Of note, when BDNF and ephrin-A5
were applied together, short-term activation (i.e. 20 min) of Eph
forward signaling counteracted BDNF-evoked induction of the
IEGs c-fos, Egr1, Egr2 and Arc (Fig. 4B, D, F, H). Now, mRNA
abundance of IEGs almost returned to control level. This
counteraction of BDNF-mediated IEG responses by ephrin-A5
was not seen at a longer ephrin-A5 exposure time (i.e. 4h; Fig. 4C,
E, G, I). This observation is in line with EphA forward signaling
reaching its maximum intensity (as assessed by P-EphA3) between
10 – 60 mins of ephrin-A5 exposure and decreasing at longer
incubation times (see Fig. 2A).
We next investigated whether modulation of a BDNF-mediated
IEG induction by ephrin-A5 is a general feature of repulsive
guidance cues. Short-term addition (20 min) of Semaphorin 3A,
an established growth cone collapsing agent [58], was unable to
repress BDNF-evoked IEG responses (Fig. S2). This result
indicates a rather specific property of ephrin-As on neurotrophin
signaling.
Finally, we asked whether the gene regulator SRF is required
for these short-term neurotrophin-mediated IEG responses
(Fig. 4B, D, F, H). Our data, employing Srf mutant neurons,
suggest that the BDNF induced IEG response requires SRF. This
is supported by a reduced induction of the IEGs Egr1, Egr2, Arc
(Fig. 4D, F, H) and to a lesser extent c-fos (Fig. 4B) in Srf mutant
neurons.
Taken together, Eph forward signaling modulates neurotrophin
mediated IEG induction.
ERK signaling is involved in decreasing BDNF-induced
gene activity via Eph receptors
Data provided so far suggest that ephrin-A5 might counteract
BDNF-mediated gene expression and growth cone responses via
decreasing ERK activity and nuclear localization (Figs. 2 and 3).
To test this hypothesis more directly, we analyzed whether Eph
forward signaling can still suppress BDNF-stimulated IEG
induction and growth cone collapse when ERK kinase activity
was experimentally raised. For this, ERK activity was elevated by
expressing constitutively-active MEK1 (CA-MEK1), an ERK
upstream activator, in cortical neurons (Fig. S3). Subsequently,
neurons were subjected to either an ephrin-A5 mediated growth
cone collapse assay (Fig. 5) or stimulated with guidance cues for 20
minutes and IEG mRNA levels were quantified via qRT-PCR
(Fig. 6).
First of all, we analyzed the impact of CA-MEK1 on neurite
outgrowth and ephrin-A5 mediated growth cone responses (Fig. 5).
The average neurite length of neurons overexpressing CA-MEK1
(Fig. 5B) was clearly reduced compared to control GFP expressing
neurons (Fig. 5A; see quantification in (G)). Growth cones of GFP
(C) and CA-MEK1 expressing neurons were similar and
protruded many filopodia (arrows in Fig. 5C-F). CA-MEK1
expression in growth cones was confined to individual dot-like
structures (arrowheads in Fig. 5D, F). Ephrin-A5 application on a
GFP expressing control growth cone (Fig. 5E) resulted in a growth
cone collapse as revealed by reduced overall growth cone area and
filopodia number (quantified in Fig. 5H, I). In contrast, in neurons
overexpressing CA-MEK1 (Fig. 5F), ephrin-A5 induced only a
partial growth cone collapse. Thus, growth cone area and
filopodia number were not reduced (see Fig. 5H, I). This result
suggests that an ephrin-A5 induced signaling cascade targets MAP
kinase signaling to exert a full growth cone collapse. This result is
in contrast to a recent report [46] which excluded ERK signaling
downstream of an ephrin-A5 mediated growth cone collapse.
Next, we tested whether ephrin-A5 signaling suppresses ERK
kinase signaling also to interfere with BDNF-mediated gene
expression (Fig. 6). In agreement with previous results (Fig. 4), in
mock-electroporated neurons, ephrin-A5 incubation reduced the
BDNF-mediated up-regulation of c-fos (Fig. 6A), Egr1 (Fig. 6B),
Egr2 (Fig. 6C) and Arc (Fig. 6D) mRNA. In contrast, in neurons
Figure 3. Eph forward signaling prevents nuclear ERK translocation. Wild-type hippocampal neurons were treated with guidance cues as
indicated, followed by staining for P-ERK (green), DAPI (blue) and F-actin (red). Arrows point at the nucleus. (A-D) In untreated neurons, nuclear P-ERK
levels were low. (E–H) BDNF enhanced P-ERK levels, which accumulated in and around the nucleus. (I–L) Ephrin-A5 did not increase nuclear P-ERK
accumulation. However, P-ERK positive clusters were observed in the neurite (arrowhead in I). (M-P) Ephrin-A5, when applied along with BDNF,
antagonized nuclear P-ERK entry evoked by BDNF. As with ephrin-A5 (I), P-ERK localized to neurites (arrowheads in M). (Q) Quantification of nuclear P-
ERK. The ratio of P-ERK in the nucleus vs. cytosol was plotted against the three time-points of stimulation. Values of ratios for untreated neurons were
set to 1. Statistical significance is provided relative to control (untreated) values. (R-U) Total ERK levels remained constant throughout the various
treatments. (V) Hippocampal neurons stained for P-ERK localization. Ephrin-A5 stimulation induces clusters of P-ERK in neurites. (W) All Eph receptors
bound by ephrin-A5 were labeled. Typically, Eph receptors were found in clusters localized to the neurites. (X) A merged image of (V) and (W),
revealing co-localization of P-ERK and Eph receptors in hippocampal neurites. Scale-bar (A-P, R-X) = 10 mm.
doi:10.1371/journal.pone.0026089.g003
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PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26089Figure 4. The BDNF-evoked neuronal IEG response is counteracted by ephrin-A5 co-application. Wild-type (black bars) and Srf mutant
(white bars) cortical neurons were treated for 20 minutes (A, B, D, F, H) or 4h (C, E, G, I) with guidance cues, followed by quantification of mRNA levels
of indicated genes. (A) Srf mRNA levels were not altered by any treatment. In conditional Srf mutant cultures, Srf mRNA levels are reduced
approximately two-fold compared to wild-type. (B, D, F, H) Expression of the IEGs c-fos (B), Egr1 (D), Egr2 (F) and Arc (H) was up-regulated in wild-type
neurons by BDNF, but not ephrin-A5 alone. Ephrin-A5 inhibited BDNF-evoked IEG up-regulation in wild-type neurons. As revealed by Srf mutant
neurons, BDNF-induced gene regulation of Egr1, Egr2, Arc and weaker c-fos required SRF. (C, E, G, I) Long-term exposure to BDNF, but not ephrin-A5
alone, elevated expression of the IEGs c-fos (C), Egr1 (E), Egr2 (G) and Arc (I) in wild-type neurons. At this extended exposure (4h) to both guidance
cues, co-application of ephrin-A5 failed to decrease BDNF-stimulated gene expression. This is inline with the activation profile of Eph receptors
reaching their maximum at 10-60 mins after ephrin-A5 addition (see Fig. 2).
doi:10.1371/journal.pone.0026089.g004
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PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26089over-expressing CA-MEK1, ephrin-A5 could not suppress BDNF-
induced IEG responses to the same degree. Particularly Egr1
(Fig. 6B) and Egr2 (Fig. 6C) mRNA levels were almost identical
when comparing neurons treated with BDNF alone and neurons
with BDNF and ephrin-A5 together.
Thus, ephrin-A5 represses gene activity elicited by BDNF at
least in part via MAP kinases.
Besides IEGs, we inspected the influence of both guidance cues
on cytoskeletal genes, whose gene products might modulate
cytoskeletal dynamics evoked by ephrin-As and/or neurotrophins
(Fig. S4). Therefore, the filamentous actin (F-actin) stabilizing
tropomyosins (Tpm1 and Tpm2), the F-actin cross-linker alpha-
actinin 1 (Actn1) and the motor protein dynein light chain 1 (Dnal1)
were analyzed. mRNA levels of other cytoskeletal genes were not
altered by any of the guidance cues (i.e. cofilin, filamin A, mena,
vinculin and smooth muscle actin; data not shown). Short-term
stimulation with guidance cues did not result in major alterations
of cytoskeletal mRNA levels except for upregulation of Tpm1 by
ephrin-A5 (Fig. S4A). At 16h of incubation, both tropomyosin
genes were induced by BDNF and ephrin-A5 alone and both
together (Fig. S4B, D). Actn1 levels were induced by individual
application of ephrin-A5 and BDNF and by co-application of both
(Fig. S4F). A similar profile was observed for the dynein light chain
(Fig. S4H).
Taken together, cytoskeletal gene expression was modulated by
ephrin-A5 and BDNF. In contrast to the antagonistic impact on
the IEG gene response (Figs. 4 and 6), ephrin-A5 and BDNF
resulted in rather synergistic action on cytoskeletal gene expres-
sion. This difference might be due to short-term (i.e. 20 minutes)
vs. long-term (i.e. 16h) exposure of both guidance cues in the IEG
and cytoskeletal gene response, respectively.
EphA7 modulates growth cone morphology yet is
dispensable for ephrin-neurotrophin communication
In order to uncover a specific Eph receptor family member
(EphA1-EphA8, EphB2) transducing ephrin-A5’s impact on
neurotrophin signaling, EphA7 was further analyzed (Fig. 7).
EphA7 is expressed on hippocampal neurons (e.g. [59]) and
EphA7 ablation results in aberrant axon guidance processes [15].
Therefore EphA7 might be potential candidate receptor for
Figure 5. Constitutively-active MEK1 blocks ephrin-A5 mediated growth cone collapse. Wild-type neurons were electroporated with
vectors expressing GFP (control; A, C, E) or expressing a FLAG-tagged constitutively-active MEK1 (CA-MEK1; B, D, F). Neurons were treated with
ephrin-A5-Fc for 30 min followed by visualization of GFP (A, C, E) or CA-MEK-1 (green in B, D, F), F-actin and ßIII tubulin. (A, B) Overexpression of CA-
MEK1 (B) reduces mean neurite length compared to a control GFP-expressing neuron (A). (C-F) A control growth cone without ephrin-A5 application
(C) typically protrudes multiple filopodia (arrow). CA-MEK-1 expressing growth cones (D) were indistinguishable from a GFP-expressing growth cone.
Note that CA-MEK1 was expressed in a dot-like pattern in the growth cone (arrowheads in D and F). Upon ephrin-A5 application, a control growth
cone (E) collapsed resulting in only few filopodia. In contrast, a CA-MEK1 expressing growth cone (F) was only partially collapsed and many filopodia
structures were preserved after ephrin-A5 induction. (G) Quantification of average neurite length. (H, I) Quantification of growth cone area (H) and
filopodia number/growth cone (I) in the four conditions. Ephrin-A5 induces a growth cone collapse, resulting in reduced growth cone area and
filopodia number in GFP but not CA-MEK1 expressing neurons. Scale-bar (A, B) = 10 mm; (C-F) = 2 mm.
doi:10.1371/journal.pone.0026089.g005
Figure 6. Ephrin-A5 suppresses BDNF-induced IEG responses via MAP kinase signaling. Wild-type cortical neurons, mock-electroporated
(black bars) or with a vector expressing constitutively-active MEK1 (white bars), were treated with guidance cues for 20 minutes as depicted, followed
by mRNA quantification. In mock-electroporated neurons, BDNF induced an IEG response of c-fos (A), Egr1 (B), Egr2 (C) and Arc (D). Co-application of
ephrin-A5 and BDNF reduced mRNA levels of all four IEGs in mock-electroporated neurons (A-D). In contrast, expression of constitutively-active MEK1
prevented Eph forward signaling from suppressing BDNF-evoked IEG responses. This was most evident for the IEGs Egr1 (B) and Egr2 (C).
doi:10.1371/journal.pone.0026089.g006
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PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e26089Figure 7. EphA7 modulates growth cone morphology yet is dispensable for ephrin-neurotrophin communication. Hippocampal
neurons derived from wild-type (A, C) and EphA7 deficient mice (B, D) were stained for DAPI (blue), tubulin (green) and F-actin (red) expression.
Individual growth cones in (A–D) are labeled by an arrow. (A–D) The area of individual growth cones of wild-type neurons (A; higher magnification in
C) exceeds that of EphA7 deficient growth cones (B; higher magnification in D). Filopodia length and number was elevated in EphA7 deficient growth
cones compared to control. (E) Quantification of growth cone area. Epha7 mutant growth cone area was reduced almost two-fold compared to wild-
type. (F) The length of individual filopodia is increased in EphA7 deficient growth cones compared to wild-type. (G, H) The total number of filopodia/
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hippocampal neurons.
Hippocampal neurons derived from wild-type or EphA7
deficient mice were indistinguishable with regard to overall neurite
length (data not shown). In contrast, growth cone morphology of
Epha7 mutant neurons (arrows Fig. 7B, D) was altered compared
to wild-type (arrows Fig. 7A, C). EphA7 deficient cultures were
readily distinguishable from control cultures by the reduced overall
area taken up by individual growth cones (Fig. 7E). Although
overall growth cone area was reduced (Fig. 7E), filopodia length
and number were increased upon EphA7 deletion (Fig. 7F–H).
Next, sensitivity of Epha7 mutant neurons towards ephrin-A5
was tested in the growth cone collapse assay (Fig. 7I). Employing
three different ephrin-A5 concentrations, we observed a full
growth cone collapse response for both wild-type and EphA7
deficient neurons. This result suggests that EphA7 is not a crucial
EphA receptor on hippocampal neurons for mediating ephrin-As
repulsive guidance activity. Also, due to the promiscuity in
Eph-ephrin interactions (see introduction) other Eph receptors
expressed on hippocampal growth cones (e.g. EphA4, EphA5,
EphA6, EphB2) might transduce ephrin-A5’s collapsing activity.
Finally we tested whether ephrin-A5 requires EphA7 to repress
neurotrophin mediated neuronal motility (Fig. 7J). Similar to wild-
type neurons, we observed that co-application of ephrin-A5 and
BDNF in EphA7 deficient growth cones still resulted in a decrease
of the growth cone area (Fig. 7J) as well as filopodia length and
number (data not shown). This suggests that EphA7 is not required
to transmit ephrin-A5’s impact on neurotrophin signaling. As
above, other Eph receptors are likely compensating for EphA7
deficiency or fulfill the major ephrin-A5 receptor function to
interact with neurotrophin signaling.
In sum, EphA7 modulates growth cone morphology yet is
dispensable as ephrin-A5 receptor to suppress neurotrophin
signaling.
Discussion
In this study, we explored consequences of primary neurons
stimulated simultaneously with two guidance cues, ephrin-A5 and
BDNF. BDNF application on primary hippocampal neurons
resulted in enhanced growth cone dynamics and branch formation
(Fig. 1, Fig S1). These findings are in line with the ‘‘attractive’’
guidance properties reported for BDNF [16,19,21,23,60]. Eph
forward signaling counteracted filopodial dynamics and neurite
formation/branching induced by BDNF (Fig. 1 and Fig. S1). How
might these findings translate to axon guidance processes in the
hippocampus in vivo? Similar to axonal pruning in the visual system
[16,19], BDNF might promote the initial overshooting of
hippocampal axons by stimulating branching. Subsequently,
ephrin-A5 might via EphA and potentially also EphB2 forward
signaling trigger axonal retraction, e.g. pruning of hippocampal
infrapyramidal mossy fiber axons. In line with this model is a
reported function of Eph family members in hippocampal pruning
in vivo [5,7]. In addition to Eph forward signaling, ephrin-A reverse
signaling is likewise suppressing BDNF-mediated branch forma-
tion [16]. Thus, both reverse and forward signaling by Eph family
members counteracts BDNF activity. The Eph/BDNF interaction
has been recently shown to be not only important for processes of
axon guidance but also synapse function [61].
How and where do ephrin-A and BDNF signaling interact? We
have not observed co-localization of EphA and TrkB receptors
(data not shown) and individual receptor activation was not
impaired by BDNF and ephrin-A5 co-application (Fig. 2). This
argues against direct interaction at the level of the Eph and TrkB
receptor and points at an interaction taking place on converging
intracellular signaling cascades as observed for the EphA and Ret
interaction before [42,62]. Indeed, data provided in this study
suggest that ephrin-A5 induced Eph forward and a BDNF induced
signaling cascade converge on ERK signaling. In line with others
[46,55], ephrin-A5 alone suppressed ERK phosphorylation. This
downregulation of P-ERK by ephrin-A5 appears to involve
phosphatases (Fig. 2C). In addition, we here show that ephrin-
A5 counteracted BDNF-induced ERK activity and reduced
therefore P-ERK levels in the nucleus (Figs. 2 and 3). Here,
ephrin-A5 does not obviously dependent on phosphatases to
reduceP-ERK levels induced by BDNF (Fig. 2D). Notably, ephrin-
A5 application resulted in P-ERK signals in the neurites, at
positions co-localizing with Eph receptors (Fig. 3). Thus, upon
activation of Eph forward signaling, P-ERK might be sequestered
in neurites and thereby precluded from nuclear transport. This,
subsequently would diminish the nuclear P-ERK pool and reduce
the activity of ERK-responding gene regulators such as SRF.
Currently, the mechanism by which Eph receptors might sequester
P-ERK in neurites is unresolved. This mechanism might involve
direct complex formation of Eph receptors and P-ERK (Fig. 3V-
X). Hence, in growth cones simultaneously activated by multiple
guidance cues, one function of Eph mediated P-ERK clustering in
neurites might be the modulation of the signaling strength of other
guidance cues as demonstrated for neurotrophins in this study.
Signaling by many receptor tyrosine kinases modulates gene
activity. Contrastingly, Eph receptor signaling has so far not been
unambiguously associated with gene transcription in neurons. We
demonstrated that ephrin-A5 can suppress BDNF-mediated gene
expression (Fig. 4). This, at least in part, appears to be mediated via
the potential of ephrin-A5 stimulated signaling to inhibit ERK
kinases (Figs. 5 and 6). How might ephrin-A5, via counteracting a
BDNF-mediated IEG response, affect neuronal motility? IEGs such
as c-fos and Egr1 can stimulate neuronal motility [63,64]. Thus,
BDNF-mediated up-regulation of these IEGs might contribute to
BDNF’s neurite- and branch promoting activity [16,21]. In such a
model, Eph receptor signaling might inhibit BDNF-induced neurite
branching by lowering IEG levels. In addition to c-fos and Egr-1
emerges Arc as an interesting IEG relevant to neuronal motility and
synapse formation [65,66]. Arc regulates actin cytoskeletal dynam-
ics by inhibiting the actin-severing protein cofilin. In addition to
IEG modulation, we observed that long-term ephrin-A5 exposure
modulates gene expression of actin cytoskeletal genes such as
tropomyosins and actinin (Fig. S3). This might be a first hint that
Eph forward signaling modulates neuronal motility also via
induction of gene activity.
Induction of all IEGs required the transcription factor SRF
(Fig. 4). So far, CREB (cyclic AMP response element binding
growth cone is increased in EphA7 deficient growth cones compared to control (G). (H) depicts the distribution (in percentage) of growth cones
harboring a certain filopodia number (1-6 and .6). The frequency of growth cones with 6 or more filopodia is almost doubled upon EphA7 deletion.
(I) EphA7 is dispensable for transducing ephrin-A5 collapsing activity in hippocampal neurons. Addition of three concentrations of ephrin-A5 resulted
in a comparable growth cone collapse induction in wild-type and EphA7 deficient neurons. (J) EphA7 is not required for ephrin-A mediated
suppression of BDNF-evoked growth cone motility. In the absence of EphA7, ephrin-A5 and BDNF co-administration reduced the growth cone area
(J), filopodia length and number (data not shown) elevated by BDNF alone. Scale-bar (A, B) = 10 mm; (C, D) = 5 mm.
doi:10.1371/journal.pone.0026089.g007
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neurotrophin-induced gene expression [29]. Our data, together
with others [30,32], suggest that in addition to CREB, SRF
emerges as transcription factor activated by neurotrophins. In
primary neurons investigated in this study, CREB was unable to
compensate for SRF-deficiency (Fig. 4). This study did not resolve
whether gene products transcribed by SRF upon activation by
BDNF are subsequently anterogradely transported and are
required to mediate BDNF’s impact on growth cone function. It
also should be noted that actin cytoskeletal dynamics in growth
cones of SRF-deficient neurons might be generally impaired in
such way that many guidance cues including ephrins, BDNF and
semaphorins might not be able to modulate growth cones
according to their usual outcome (e.g. collapse or filopodia
extension).
Eph activation does not only counteract neurotrophin signaling
as shown in this study and by others [46]. In addition, EphA
forward signaling was reported to suppress FGF signaling [46].
Thus, such a repressive function on ERK signaling and gene
activity which in principle could be exerted by multiple Eph family
members (see introduction) might modulate receptor tyrosine
kinase signaling in many biological functions including organo-
genesis and tumorigenesis [11].
Supporting Information
Fig. S1 BDNF stimulated neurite branching is antago-
nized by Eph forward signaling. Cultures were incubated
with ephrin-A5 and BDNF at the indicated combinations for three
days, followed by staining for F-actin (red) and microtubules
(green). (A, B) Untreated wild-type neurons (A) protruded multiple
neurites and neurite length was increased compared to SRF-
deficient neurons (B). (C, D) BDNF alone enhanced neurite
numbers in wild-type (arrows in C), but not Srf mutant neurons
(D). (E, F) Ephrin-A5 did not alter neurite numbers in wild-type (E)
or SRF-deficient (F) neurons. (G, H) Ephrin-A5 antagonized the
BDNF-stimulated increase in neurite branching in wild-type
neurons (G). In Srf mutant neurons, no modulation of neurite
numbers by ephrin-A5 and BDNF co-application was observable
(H). (I, J) Quantification of average neurite (I) and branch (J)
number. Statistical significance was calculated in relation to wild-
type/control treatment. (K) BDNF-mediated increase in neurite
number requires MEK as revealed by U-0126 application, a MEK
inhibitor. *, P,0.05; **, P,0.01; ***, P,0.001. Error bars
represent s.d. Scale-bar (A-H) = 50 mm.
(DOC)
Fig. S2 Unlike ephrin-As, the repulsive guidance cue
semaphorin-3A does not antagonize BDNF-meditated
IEG induction. Cortical neurons were stimulated for 20 mins
with 2.5 ng/ml BDNF, supernatant of HEK293 cells transfected
with either GFP (control; ctr.) or semaphorin 3A (sema3A) or
BDNF together with sema3A. Subsequently, RNA was isolated
and cDNA was subjected to qPCR using primers to IEGs
indicated. Growth cone collapse experiments were performed in
parallel to confirm repulsive activity of sema3A supernatants used
in qPCR experiments. Numbers in bars indicate numbers of
independent cultures used. The IEGs Arc (A), c-fos (B), Egr1 (C) and
Egr2 (D) were induced by BDNF. Interestingly, Arc (A) and Egr2
(D) were slightly induced by semaphorin 3A alone. Co-application
of BDNF and sema3a resulted in robust induction of all IEGs
tested to an extent comparable to BDNF alone. Thus, the
repulsive guidance cue semaphorin 3A does not, unlike ephrin-A5,
suppress BDNF-induced IEG mRNA levels.
(DOC)
Fig. S3 Constitutively-active MEK1 (caMEK1) elevates
P-ERK levels. Neurons were electroporated with indicated
amounts of a plasmid expressing caMEK-FLAG. After two days in
culture, cell lysates were prepared and subjected to Western
Blotting with antibodies indicated. P-Erk levels were increased by
overexpression of caMEK compared to mock-electroporated
neurons.
(DOC)
Fig. S4 Alterations in cytoskeletal gene expression upon
exposure to ephrins and BDNF. Wild-type cortical cultures
were treated for 20 minutes (A, C, E, G) or 16h (B, D, F, H) with
guidance cues as depicted, followed by quantification of mRNA
levels of indicated genes by qRT-PCR. (A, B) Tropomyosin1
(Tpm1) was up-regulated within 20 minutes by ephrin-A5 alone
(A). 16h exposure to BDNF, ephrin-A5 alone and both together
resulted in elevated Tpm1 mRNA levels (B). (C, D) Tropomyosin2
(Tpm2) was, within this 20 minute stimulation, not obviously
altered by any treatment (C). Contrastingly, after 16h of
incubation, BDNF slightly and ephrin-A5 alone or both together
increased more robustly Tpm2 mRNA amounts (D). (E, F)
Actinin1 (Actn1) was slightly, yet significantly, induced in wild-
type neurons by ephrin-A5 and BDNF co-application, but none of
the other treatments. With longer exposure, all three combinations
of guidance cues elevated Actn1 mRNA levels (F). (G, H) Within 20
minutes of incubation, dynein light chain (Dnal1) was not changed
by any guidance cue (G). After 16 h of application, BDNF slightly
and ephrin-A5 and both together more pronounced, elevated
Dnal1 mRNA abundance. *, P,0.05; **, P,0.01; ***, P,0.001.
Error bars represent s.d.
(DOC)
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